Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Pumosetrag

Drug Profile

Pumosetrag

Alternative Names: DDP 733; MKC 733

Latest Information Update: 04 Nov 2018

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Mitsubishi Chemical
  • Developer Dynogen Pharmaceuticals; Edusa Pharmaceuticals; Mitsubishi Chemical
  • Class Gastrokinetics; Irritable bowel syndrome therapies; Laxatives; Quinuclidines; Small molecules
  • Mechanism of Action Serotonin 5-HT3 receptor partial agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Constipation; Dyspepsia; Gastro-oesophageal reflux; Irritable bowel syndrome; Reflux oesophagitis

Most Recent Events

  • 12 Jul 2010 Phase-II clinical trials in Gastro-oesophageal reflux in USA (PO)
  • 22 May 2008 Final safety and efficacy data from a phase IIa (IBS-c) trial in Irritable bowel syndrome presented at the Digestive Disease Week 2008 (DDW-2008) ,
  • 09 Nov 2007 Phase-II clinical trials in Irritable bowel syndrome in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top